Sanofi's Brandicourt Pushes for Speedy Zika Vaccine Development

  • Drugmaker building on success of Dengvaxia dengue vaccine
  • Zika initial investment `won't be too big' thanks to Dengvaxia

Zika Virus: What You Need to Know in Two Minutes

Sanofi Chief Executive Officer Olivier Brandicourt is pushing for speedy development of a Zika virus vaccine, building on the company’s success in bringing the first inoculation against dengue to market.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.